Why is Pharmaids Pharma falling/rising?

As of 08-Sep, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 61.50, reflecting a decrease of 0.25 or 0.4%. The stock has underperformed its sector today by 0.27% and has been on a consecutive downward trend for the last two days, resulting in a total drop of 1.09% during this period. Despite a strong long-term performance with a 57.98% return over the past year and significant gains over three and five years, the company faces challenges such as operating losses and a weak long-term fundamental strength, which are contributing to its recent price decline. The stock's delivery volume has also seen a significant drop of 72.68% against the five-day average, indicating falling investor participation.
In the broader market context, Pharmaids Pharmaceuticals Ltd has outperformed the Sensex in the short term with a 0.99% gain over the past week compared to the benchmark's 0.53% increase. However, the stock's performance over the last month shows a decline of 3.70%, while the Sensex has risen by 1.16%. The company's high debt-to-EBITDA ratio and negative EBITDA further exacerbate its risk profile, making it less attractive to investors despite its historical performance. Overall, the combination of recent underperformance, declining investor interest, and fundamental weaknesses are contributing to the stock's current downward movement.